Algert Global’s Tivity Health, Inc. Common Stock TVTY Stock Holding History

Algert Global’s Portfolio TVTY Stock Details TVTY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-48,426	Closed	-$1.56M	–	1443
2022 Q1	$1.56M	Buy	+48,426	New	+$1.31M	0.1%	327
2020 Q1	–	Sell	-17,251	Closed	-$351K	–	557
2019 Q4	$351K	Buy	+17,251	New	+$323K	0.1%	242
2019 Q2	–	Sell	-10,742	Closed	-$189K	–	420
2019 Q1	$189K	Buy	+10,742	New	+$229K	0.11%	247
2018 Q2	–	Sell	-7,786	Closed	-$309K	–	401
2018 Q1	$309K	Sell	7,786 -20,495	-72%	-$796K	0.06%	287
2017 Q4	$1.03M	Buy	+28,281	New	+$1.07M	0.24%	163
2016 Q4	–	Sell	-17,274	Closed	-$457K	–	422
2016 Q3	$457K	Buy	+17,274	New	+$349K	0.13%	253

Other funds holding TVTY

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

Pacifica Partners Surrey, Canada $332M AUM 59.28% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Algert Global's TVTY Position: Q2 2022 in Review

Algert Global sold out of Tivity Health, Inc. Common Stock (TVTY) in Q2 2022, closing a stake of 48,426 shares — an estimated $1.56M sold.

Algert Global first reported a position in TVTY in Q3 2016 and held it in 6 quarters. The position peaked at $1.56M in Q1 2022. 4 funds tracked by Wall St. Rank hold TVTY as of Q2 2022.

Algert Global reported no remaining Tivity Health, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Algert Global sold 48,426 Tivity Health, Inc. Common Stock shares in Q2 2022, an estimated $1.56M.
Algert Global first reported a position in Tivity Health, Inc. Common Stock in Q3 2016 and held it in 6 quarters.
Algert Global's Tivity Health, Inc. Common Stock position peaked at $1.56M in Q1 2022.
4 funds tracked by Wall St. Rank held Tivity Health, Inc. Common Stock as of Q2 2022.

Based on Algert Global's 13F filing for Q2 2022, filed 15 Aug 2022.